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Abstract

The sensory and supporting cells (SCs) of the organ of Corti are derived from a limited
number of progenitors. The mechanisms that regulate the number of sensory progenitors are not
known. Here, we show that Fibroblast Growth Factors (FGF) 9 and 20, which are expressed in the
non-sensory (Fgf9) and sensory (Fgf20) epithelium during otic development, regulate the number of
cochlear progenitors. We further demonstrate that Fgf receptor (Fgfr) 1 signaling within the
developing sensory epithelium is required for the differentiation of outer hair cells and SCs, while
mesenchymal FGFRs regulate the size of the sensory progenitor population and the overall cochlear
length. In addition, ectopic FGFR activation in mesenchyme was sufficient to increase sensory
progenitor proliferation and cochlear length. These data define a feedback mechanism, originating
from epithelial FGF ligands and mediated through periotic mesenchyme that controls the number of
sensory progenitors and the length of the cochlea.
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Introduction
The Organ of Corti contains mechanosensory hair cells (HC) and specialized supporting cells (SC) that
are required for the transduction of sound (Wu and Kelley, 2012). The frequency spectrum of sound
stimuli is tonotopically represented along the length of the mammalian cochlea (Fay and Popper,
2000). In mouse, the cochlea begins to grow from the ventral otic vesicle at embryonic day 11.5
(E11.5) and continues to grow and coil, forming approximately one and a half turns by birth. During its
development, the length of the cochlea is limited by the number of progenitors that give rise to
sensory HCs and SCs, and is further regulated through a process of convergent extension (Chen and
Segil, 1999; Montcouquiol et al., 2003; Wang et al., 2005; Wu and Kelley, 2012). In mouse, sensory
progenitors exit the cell cycle by E14.5 and begin to differentiate into HCs and SCs. Thus, the size of
the progenitor population at this stage of development is the ultimate determinant of the size of the
adult cochlea. Progenitor number is determined by proliferation, the timing of differentiation, and in
some cases by aberrant cell death. Previous studies indicate that sensory progenitor growth requires
mesenchymal signals (Phippard et al., 1999; Montcouquiol and Kelley, 2003; Braunstein et al.,
2008, 2009), however, the identity and source of the factors that control this activity are not known.
Fibroblast Growth Factors (FGFs) have several stage-specific functions during inner ear
development. FGF3 and FGF10 signal from hindbrain and head mesenchyme, respectively, to the
overlying ectoderm to induce formation of the otic placode and vesicle (Urness et al., 2010). Later in
development, FGF20 regulates differentiation of outer hair cells (OHC) and SCs, termed the lateral
compartment of the cochlea (Huh et al., 2012). Phenotypic similarities with mice lacking Fgfr1 in the
entire otic epithelium suggest that FGF20 signals directly to FGFR1, serving as a permissive factor for
differentiation (Pirvola et al., 2002; Hayashi et al., 2008; Huh et al., 2012). FGF9 signaling regulates
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eLife digest Mammalian ears contain several structures that are involved in hearing. Within the
inner ear is a spiral-shaped structure called the cochlea. This contains an array of cells called sensory
hair cells that convert sound vibrations into electrical signals, which are then conveyed to the brain.
Sounds of differing pitch are detected at different points along the cochlea, so its overall length
helps to determine the range of sounds that an individual can hear.
In the embryo, sensory hair cells and their associated supporting cells develop from ‘cochlear
progenitor’ cells. The final length of the cochlea is determined by the numbers of progenitor cells
that commit to becoming either sensory hair cells or supporting cells. Two proteins called FGF9 and
FGF20 are involved in the formation of the cochlea. FGF20 promotes the formation of the hair cells
and supporting cells, but the precise roles of both proteins are not clear.
Here, Huh et al. studied FGF9 and FGF20 in the inner ear of mice at an early stage of
development. The experiments show that these proteins work together to control the number of
progenitor cells and the length of the cochlea. FGF20 is produced by the same tissue structure
(called an ‘epithelium’) that gives rise to the hair cells and supporting cells. In contrast, FGF9 is
produced in another epithelium tissue that produces the cells that line the fluid-filled tubes of the
inner ear.
The experiments also show that both FGF9 and FGF20 act as signals to cells in an adjacent tissue
called the mesenchyme, where they activate other proteins known as FGF receptors. These
receptors, in turn, regulate an unknown molecule in the mesenchyme that influences the growth of
progenitor cells and the length of the cochlea.
Sensory hair cells can be injured or lost by excessive sound exposure, some medications and as
part of normal aging. These cells are not replaced, and so their loss is a major cause of permanent
hearing loss. Understanding the signals that produce the progenitor cells will take us one step closer
to being able to grow these cells in the laboratory for use in therapies to replace or repair damaged
sensory hair cells.
DOI: 10.7554/eLife.05921.002

structural components of the vestibular system, but alone has no effect on cochlear development
(Pirvola et al., 2004). During postmitotic stages, FGF8 signaling from the inner hair cell (IHC) to
FGFR3 in SCs regulates pillar cell differentiation (Colvin et al., 1996; Mueller et al., 2002; Jacques
et al., 2007).
Here, we identify another critical stage in inner ear development that requires FGF signaling. We
show that Fgf9, expressed in the non-sensory epithelium, and Fgf20, expressed in the sensory
epithelium, regulate the number of cochlear progenitors and the ultimate length of the cochlea
through signaling to mesenchymal FGFRs. We find that in vivo FGF9/20 signaling to mesenchymal
FGFR1 and FGFR2 is required for sensory progenitor proliferation and that mesenchymal FGFR
signaling is sufficient to promote sensory progenitor proliferation and extend the length of the
cochlear duct. In addition, we show that prosensory epithelial FGFR1 and FGF20 independently is
required for differentiation of outer HCs and SCs.

Results
Fgf9 and Fgf20 are expressed in the developing cochlea
In a prior study, we showed that Fgf20 is required between E13.5–14.5 for differentiation of cochlear
OHCs and SCs in the organ of Corti (Huh et al., 2012). However, Fgf20 is expressed in a portion of
the otic vesicle sensory epithelium much earlier in development, beginning at E10.5 (Huh et al.,
2012), but analysis of mice lacking Fgf20 did not reveal any function for Fgf20 at this stage of
development. Since there are many examples of FGFs functioning redundantly during development,
we hypothesized that redundancy could account for the lack of a phenotype in Fgf20 null inner ears
between E10.5 and 12.5. Fgf9 is closely related to Fgf20 (Zhang et al., 2006; Itoh and Ornitz, 2008),
and is also expressed in the otic epithelium at E10.5–12.5 (Pirvola et al., 2004); however, Fgf9−/−
mice have normal cochlear development and normal patterning of the organ of Corti (Pirvola
et al., 2004).
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We first examined the expression domain of Fgf9 relative to Sox2-expressing sensory progenitors
(and Fgf20) using a new Fgf9-βGal reporter allele (Fgf9lacZ) in which a splice acceptor-lacZ gene was
inserted into the first intron of Fgf9 (Skarnes et al., 2011). At E10.5, βGal activity was detected in the
otic vesicle epithelium (Figure 1A). Co-staining of βGal and Sox2 at E11.5 showed no overlap,
indicating that Fgf9 is expressed in the non-sensory epithelium of the otic vesicle (Figure 1B). Taken
together with previous Fgf20 expression analysis at this stage (Huh et al., 2012, Figure 1C), Fgf9 and
Fgf20 are both expressed in the otic vesicle, but in non-overlapping domains in the otic epithelium
(Figure 1D).

Fgf9 and Fgf20 regulate cochlear length and Fgf20, not Fgf9, is required
for lateral compartment differentiation and patterning
To determine whether Fgf9 and Fgf20 could have a redundant role in cochlear development, Fgf9;
Fgf20 double knockout cochleae were analyzed at E18.5 by staining with phalloidin and with an
antibody to p75 to identify sensory HCs and pillar cells, respectively (Figure 2A–C). Control embryos
(Fgf9−/+;Fgf20lacZ/+) showed a normal pattern of three rows of OHCs and one row of IHCs throughout
the cochlear duct (Figure 2A–C). Fgf9−/− and Fgf9−/−;Fgf20lacZ/+ cochleae showed the same wild type
HC pattern as the double heterozygous controls (Figure 2A–C). Fgf20lacZ/lacZ and Fgf9−/+;Fgf20lacZ/lacZ
cochleae showed patches of sensory HCs and gaps (Figure 2A–C) (Huh et al., 2012). Fgf9−/−;Fgf20lacZ/lacZ
cochleae also showed a similar patterning phenotype to Fgf20lacZ/lacZ mice (Figure 2A–D). The density
(number of cells per 100 μm) of OHCs in Fgf9−/− and Fgf9−/−;Fgf20lacZ/+ cochleae was similar to double
heterozygous controls (Figure 2E). However, the densities of OHCs in Fgf20lacZ/lacZ, Fgf9−/+;Fgf20lacZ/lacZ
and Fgf9−/−;Fgf20lacZ/lacZ cochleae were similar to each other (ANOVA, p > 0.1), and significantly
(ANOVA, p < 0.0001) decreased compared to double heterozygous controls (Figure 2E). Densities of
IHCs were comparable in all genotypes
(Figure 2E). To analyze SCs, cochleae were
immunostained for Prox1 and Sox2 (Figure 2D).
In double heterozygous control cochleae, 5 rows
of Prox1+ SCs overlapped with Sox2 staining
(Figure 2D). Fgf9−/− and Fgf9−/−;Fgf20lacZ/+ cochleae showed a similar pattern (Figure 2D). In
contrast, Fgf20lacZ/lacZ, Fgf9−/+;Fgf20lacZ/lacZ and
Fgf9−/−;Fgf20lacZ/lacZ cochleae showed patches of
SCs separated by gaps of Sox2+, Prox1− cells
(Figure 2D). The density of SCs in Fgf9−/− and
Fgf9−/−;Fgf20lacZ/+ was comparable (ANOVA, p >
0.5) to double heterozygous control (Figure 2F).
The density of SCs in Fgf20lacZ/lacZ, Fgf9−/+;
Fgf20lacZ/lacZ and Fgf9−/−;Fgf20lacZ/lacZ were similar
to each other (ANOVA, p > 0.3) and significantly
(ANOVA, p < 0.0001) decreased compared to
double heterozygous controls (Figure 2F).
One of the striking differences among Fgf9;
Fgf20 compound mutants was cochlear length.
The length of Fgf9−/− and Fgf9−/−;Fgf20lacZ/+ cochleae was comparable (ANOVA, p > 0.1) to that
of double heterozygous controls (Figure 2G),
Figure 1. Fgf9 and Fgf20 are expressed in distinct
regions of the otic vesicle. (A) βGal activity in an
whereas the length of Fgf20lacZ/lacZ and Fgf9−/+;
lacZ/+
Fgf9
embryo at E10.5 visualized with xGal staining.
Fgf20lacZ/lacZ cochleae was 16% and 18% shorter
(B, C) βGal (red) and Sox2 (green) co-immunostaining
than double heterozygous controls (p < 0.05 and
showing that Fgf9 (B) is expressed in Sox2- non-sensory p < 0.001), respectively, and the length of Fgf9−/−;
epithelium and Fgf20 (C) is expressed in Sox2+ sensory
Fgf20lacZ/lacZ cochleae was reduced by 58% comepithelium at E11.5. (D) Schematic diagram of FGF9,
pared to controls (p < 0.001) (Figure 2G). In
FGF20, and Sox2 immunostaining showing that FGF9
addition, Fgf9−/−;Fgf20lacZ/lacZ double knockout
and FGF20 are expressed in distinct domains in the otic
cochleae were 49% and 51% of the length
vesicle. ov, otic vesicle, scale bars, 100 μm.
of Fgf20lacZ/lacZ and Fgf9−/+;Fgf20lacZ/lacZ cochleae
DOI: 10.7554/eLife.05921.003
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Figure 2. Fgf9 and Fgf20 regulate cochlear length. (A, B) Phalloidin (A) and p75 immunostaining (B) of E18.5 whole
cochlea showing hair cells (HCs) (phalloidin) and pillar cells (p75) in the cochlear duct of Fgf9−/+;Fgf20lacZ/+, Fgf9−/−,
Fgf20lacZ/lacZ, Fgf9−/−;Fgf20lacZ/+, Fgf9−/+;Fgf20lacZ/lacZ and, Fgf9−/−;Fgf20lacZ/lacZ embryos. (C) Phalloidin (green) and p75
immunostaining (red) showing the orientation of HCs, pillar cells, and gaps in the sensory epithelium. (D) Prox1 (green)
and Sox2 (red) co-immunostaining showing supporting cells (SCs) (yellow, Prox1 and Sox2) and undifferentiated
sensory progenitors (red, Sox2). (E–G) Measurement of HC number (E), SC number (F), and length of cochleae (G) of
E18.5 embryos. Scale bars, A, 500 μm; C, 100 μm. For statistical analysis, all samples were compared with Fgf9−/+;
Fgf20lacZ/+ double heterozygous controls. *p < 0.001. Sample numbers (n) are indicated in data bars.
DOI: 10.7554/eLife.05921.004

(p < 0.001), respectively (Figure 2G). These data identify a redundant role for Fgf9 and Fgf20 to attain
the proper cochlear length, while Fgf20, alone, primarily regulates cochlear patterning and
differentiation.
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Fgf9 and Fgf20 regulate sensory progenitor cells proliferation
We hypothesized that the overall length of the cochlear duct would correlate with the size of the
postmitotic prosensory domain. In mouse, cochlear sensory progenitors exit the cell cycle beginning
at E12.5 in the apex and progressing towards the base by E14.5 (Lee et al., 2006). E14.5 cochleae
were dissected and immunostained for Sox2 (Figure 3A), which marks the lineage of cells that will
become HCs and SCs (Kiernan et al., 2005). The Sox2+ prosensory domain of double heterozygous
control and Fgf9−/+;Fgf20lacZ/lacZ inner ears were similar (Figure 3A). However, the Sox2+ prosensory
domain of Fgf9−/−;Fgf20lacZ/lacZ inner ears were clearly smaller than that of double heterozygous
control or Fgf9−/+;Fgf20lacZ/lacZ cochleae (Figure 3A). Immunostaining of histological sections of E14.5
inner ears showed that the Sox2+ prosensory domain was less compact in Fgf9−/−;Fgf20lacZ/lacZ inner
ears compared to double heterozygous control and inner ears with one wild type allele of Fgf9
(Figure 3B). Immunostaining for p27kip1 (Cdkn1b) showed a very similar pattern to that of Sox2, with
more diffuse cells in the prosensory domain of E14.5 inner ears of Fgf9−/−;Fgf20lacZ/lacZ mice
(Figure 3C). Jag1, which marks the medial prosensory cells that will give rise to IHCs, inner SCs, and
Kölliker’s organ (Ohyama et al., 2010; Basch et al., 2011), showed a similar expression pattern across
all three genotypes, indicating that the medial compartment of the cochlea was correctly specified
(Figure 3D).
To determine whether the decreased size of the Fgf9−/−;Fgf20lacZ/lacZ prosensory domain resulted
from changes in cell proliferation and/or cell death, histological sections of E11.5 and E12.5 otic
vesicles were immunostained for Sox2 and phospho-Histone H3 (pHH3) (Figure 3E,F), or activated
Caspase-3 (aCasp3) (data not shown). Quantification of the number of pHH3+, Sox2+ sensory
progenitors showed similar numbers (p > 0.09 at E11.5 and p > 0.2 at E12.5) in double heterozygous
control and Fgf9−/+;Fgf20lacZ/lacZ cochleae (Figure 3G,H). However, proliferation of Fgf9−/−;Fgf20lacZ/lacZ
cochlear epithelial cells was significantly decreased at E11.5 (p < 0.001) and E12.5 (p < 0.01)
compared to double heterozygous controls (Figure 3G,H). In addition quantitation of cell
proliferation using EdU labeling of E11.5 embryos showed similar results (Figure 3—figure
supplement 1). No cell death (aCasp3+) was detected in any of the genotypes at E11.5 and E12.5
(data not shown).
Decreased sensory progenitor number could also result from premature cell cycle exit. p27kip1 is
one of the cell cycle inhibitors that is expressed in sensory progenitors as they become postmitotic.
Expression of p27kip1 begins at E12.5 in the apex of the cochlea and progresses towards the base (Lee
et al., 2006). By E14.5, the entire cochlear progenitor domain becomes p27kip1 positive. Expression of
p27kip1 at E12.5 in the proximal cochlear duct was not detected in either control or Fgf9−/−;Fgf20lacZ/lacZ
embryos suggesting that there is no premature cell cycle exit in mice lacking Fgf9 and Fgf20
(Figure 3—figure supplement 2).

Epithelial Fgfr1 but not Fgfr2 is required for lateral compartment
differentiation
Next, we questioned which cell types are required for sensory progenitor proliferation and/or lateral
compartment differentiation. Expression of both Fgfr1 and Fgfr2 have been reported in the otic
epithelium and periotic mesenchyme between E10.5 and E12.5 (Pirvola et al., 2000, 2002, 2004;
Ono et al., 2014). Epithelial Fgfr1 has been conditionally inactivated in otic epithelium using Foxg1Cre,
Six1enh21Cre, and Emx2Cre (Pirvola et al., 2002; Ono et al., 2014). This results in a cochlear
epithelium with reduced numbers of HCs, with OHC numbers being more severely affected than IHC
numbers. In addition to the loss of differentiated HCs, a 40–50% decrease in cochlear length was
reported when Fgfr1 was inactivated with Six1enh21Cre, or Emx2Cre (Ono et al., 2014).
To directly compare cochlear phenotypes resulting from inactivation of Fgfr1 in otic epithelium
with embryos lacking Fgf9 and Fgf20, we re-created and re-evaluated Fgfr1−/f::Foxg1Cre/+ mutant mice
maintained on a 129X1/SvJ;C57BL/6J mixed genetic background. Quantification of the density of
OHCs in Fgfr1−/f::Foxg1Cre/+ embryos demonstrated a significant (p < 0.0001) decrease compared to
controls (Fgfr1+/f::Foxg1Cre/+) (Figure 4—figure supplement 1A,B,E), while the density of IHCs was
not changed (p > 0.09). Furthermore, the length of Fgfr1−/f::Foxg1Cre/+ cochleae was only 9% shorter
than control (Figure 4—figure supplement 1A,B,F), similar to what was observed in Fgf20lacZ/lacZ
embryos (Figures 1B, 2G and ref. Huh et al., 2012). Whole mount Sox2 staining of E14.5
Fgfr1−/f::Foxg1Cre/+ cochleae was also comparable to control, indicating that the number of Sox2+
progenitors was not changed (Figure 4—figure supplement 1C). In addition, proliferation of the
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Figure 3. Fgf9 and Fgf20 are required for sensory progenitor proliferation. (A) Sox2 immunostaining of whole E14.5 cochlea to identify the progenitor
domain (arrows). (B–D) Sox2 (B), p27 (C), and Jag1 (D) immunostaining of E14.5 Fgf9−/+;Fgf20lacZ/+, Fgf9−/+;Fgf20lacZ/lacZ, and Fgf9−/−;Fgf20lacZ/lacZ embryo
sections. Boxed regions of the cochlear duct are magnified below each image and were chosen in regions where the sections perpendicularly transect
the cochlear duct. (E, F) Sox2 and phospho-Histone H3 (pHH3) co-immunostaining of E11.5 (E) and E12.5 (F) Fgf9−/+;Fgf20lacZ/+, Fgf9−/+;Fgf20lacZ/lacZ and,
Fgf9−/−;Fgf20lacZ/lacZ embryo sections. (G, H) Measurement of Sox2+ sensory progenitor proliferation at E11.5 (G) and E12.5 (H). All samples were compared
with Fgf9−/+;Fgf20lacZ/+ double heterozygous controls. *p < 0.01, **p < 0.001. Sample numbers (n) are indicated in data bars. See also Figure 3—figure
supplements 1, 2.
DOI: 10.7554/eLife.05921.005
The following figure supplements are available for figure 3:
Figure supplement 1. Proliferation of sensory progenitors.
DOI: 10.7554/eLife.05921.006
Figure supplement 2. Fgf9 and Fgf20 loss do not cause premature cell cycle exit.
DOI: 10.7554/eLife.05921.007

Fgfr1−/f::Foxg1Cre/+ prosensory epithelium was comparable (p > 0.6) to that of controls at E12.5
(Figure 4—figure supplement 1D,G).
Because Fgfr2 often exhibits redundancy with Fgfr1, it is important to consider potential Fgfr2
function in the inner ear prosensory epithelium. However, Fgfr2 is required for formation of the otic
vesicle and Foxg1Cre, which is active before and during the otic vesicle stage (Hébert and McConnell,
2000), could not be used to investigate the role of Fgfr2 at later stages of otic vesicle development. In
addition, due to overall activity of Foxg1Cre in the otic vesicle, cell type specificity of Fgfr1 was still
unknown. To study whether Fgfr1 and/or Fgfr2 function cell autonomously or non-cell autonomously
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in the Fgf20+ domain of the prosensory epithelium, we generated an Fgf20Cre allele (Figure 4—figure
supplement 2A) to allow conditional gene targeting of the Fgf20 lineage. To assess Cre activity,
Fgf20Cre/+;ROSAmTmG/+ mice were generated. Cre activity was detected at E10.5 in a subset of the
Sox2+ prosensory domain, in a pattern identical to that of Fgf20lacZ embryos (Figure 4—figure
supplement 2B). At P0, all of the components of the organ of Corti were positive for the Fgf20Cre/+;
ROSAmTmG/+ lineage tracer, indicating that Fgf20Cre is active in prosensory progenitors or their lineage
(Figure 4—figure supplement 2B).
To identify potential roles for Fgfr1 and Fgfr2 in the prosensory epithelial lineage, we generated
Fgfr1 and Fgfr2 single and double conditional mutant mice using the Fgf20Cre allele. E18.5 embryos
were harvested and stained with phalloidin and p75, to visualize cochlear morphology. The phenotype
of Fgfr1 −/f::Fgf20Cre/+(Fgfr1−/f;Fgfr2+/f::Fgf20Cre/+) cochleae was similar to that of Fgf20lacZ/lacZ,
Fgf9−/−;Fgf20lacZ/lacZ, and Fgfr1−/f::Foxg1Cre/+ cochleae (Figures 2A–C, 4A–C, Figure 4—figure
supplement 1A,B). In contrast, the pattern and morphology of Fgfr2−/f::Fgf20Cre/+(Fgfr1+/f;Fgfr2−/f::
Fgf20Cre/+) cochleae was similar to control (Figure 4A–C) and Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+ cochleae was
comparable to Fgfr1−/f::Fgf20Cre/+ (Figure 4A–C). The density of OHCs in Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+
was comparable to Fgfr1−/f::Fgf20Cre/+ (p > 0.94) and significantly (p < 0.001) decreased compared
to control (Figure 4F). The density of OHCs of Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+ embryos was comparable
to control (p > 0.6) (Figure 4F) and the density of IHCs in Fgfr1−/f::Fgf20Cre/+, Fgfr2−/f::Fgf20Cre/+, and
Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+ cochleae were indistinguishable (ANOVA, p > 0.8) from that of controls
(Figure 4F).
The length of the cochleae from E18.5 Fgfr1−/f::Fgf20Cre/+ and Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+ embryos
was decreased by 19% and 25%, respectively, compared to controls (p < 0.0001, Figure 4G).
However, the length of the cochleae from Fgfr2−/f::Fgf20Cre/+ was comparable (p > 0.5) to controls.
Together, these data, and those presented above, showed that epithelial Fgfr1, but not Fgfr2, is
required for lateral compartment differentiation, and has a modest effect on cochlear duct length of
a similar magnitude to the 10% reduction in cochlear length seen in Fgf20lacZ/lacZ mice (Huh et al.,
2012). This reduction in cochlear length could be due to reduced numbers of progenitors or to other
effects of FGFR1 signaling on cochlear duct elongation at later stages of development. Whole mount
Sox2 staining at E14.5 of Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+ cochleae showed a similarly sized sensory
progenitor domain as compared to controls indicating that the Sox2+ progenitor population was not
affected by inactivation of epithelial Fgfr1 and Fgfr2 (Figure 4D). In addition, proliferation of Fgfr1−/f;
Fgfr2−/f::Fgf20Cre/+ cochleae was comparable (p > 0.5) to controls at E12.5 (Figure 4E,H).

Mesenchymal Fgfr1 and Fgfr2 regulate cochlear length but not lateral
compartment differentiation
We next asked whether mesenchymal FGFRs regulate cochlear length. Twist2(Dermo1)Cre is widely
expressed in mesenchymal cells (Li et al., 1995; Šošić et al., 2003). To determine whether Twist2Cre is
active in periotic mesenchyme during otic vesicle development, Twist2Cre/+;ROSA26lacZ/+ embryos
were stained for lacZ activity at E9.5 and E10.5. lacZ activity was observed in all of the mesenchyme
surrounding the unstained otic epithelium at both developmental time points (Figure 5—figure
supplement 1). Twist2Cre was then used to inactivate Fgfr1 and Fgfr2 from mesenchymal cells.
Cochleae were dissected from E18.5 embryos and stained with phalloidin and p75. All genotypes
showed normal sensory HC and SC patterning, with one row of IHCs and three rows of OHCs
(Figure 5A–C). The linear density of IHCs and OHCs was comparable (ANOVA, p > 0.2, p > 0.8,
respectively) among all genotypes (Figure 5F). However, the length of the cochleae of Fgfr1
−/f
::Twist2Cre/+ (Fgfr1−/f;Fgfr2+/f::Twist2 Cre/+), Fgfr2−/f::Twist2 Cre/+ (Fgfr1+/f;Fgfr2 −/f::Twist2Cre/+),
and Fgfr1 −/f;Fgfr2−/f::Twist2 Cre/+ embryos were decreased by 7%, 20%, and 55%, respectively,
compared to control (Figure 5A,B,G). Thus, the total number of HCs is decreased in proportion
to the decreased length of the cochlea.
To determine whether the effect of loss of mesenchymal FGFRs on cochlear length originates early
in development, we examined the size of the Sox2+ progenitor domain at the time that HCs commit to
differentiate, and cell proliferation within the Sox2+ domain before the onset of differentiation. The
size of the Sox2+ progenitor domain, visualized by whole mount Sox2 staining of E14.5 cochleae was
decreased in Fgfr1−/f;Fgfr2−/f::Twist2Cre/+ embryos compared to control embryos (Figure 5D). In
addition, proliferation of Sox2+ progenitors from Fgfr1−/f;Fgfr2−/f::Twist2Cre/+ cochleae was significantly (p < 0.01) decreased compared to control cochleae at E12.5 (Figure 5E,H). Together, these
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Figure 4. Cell-autonomous regulation of sensory progenitor differentiation requires epithelial Fgfr1 but not Fgfr2. (A, B) Phalloidin (A) and
p75 immunostaining (B) of E18.5 whole cochlea showing HCs (phalloidin) and pillar cells (p75) in the cochlear duct of control, Fgfr1−/f::Fgf20Cre/+
(Fgfr1−/f;Fgfr2 +/f::Fgf20 Cre/+), Fgfr2−/f::Fgf20Cre/+ (Fgfr1+/f;Fgfr2−/f::Fgf20Cre/+ ) and, Fgfr1−/f;Fgfr2−/f::Fgf20Cre/+ embryos. (C) Phalloidin (green) and
Figure 4. continued on next page
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Figure 4. Continued
p75 immunostaining (red) showing the patterning of HCs and pillar cells in the cochlear duct. (D) Sox2 immunostaining of E14.5 whole cochlea to
identify progenitor domains (arrows). (E) Sox2 and pHH3 co-immunostaining of E12.5 embryo sections. (F, G) Measurement of HC number (F) and
length of cochleae (G) of E18.5 control embryos. (H) Measurement of Sox2+ sensory progenitor proliferation in E12.5 embryos. All samples were
compared with controls. *p < 0.001; ns, not significant. Sample numbers (n) are indicated in data bars. See also Figure 4—figure supplements 1, 2.
DOI: 10.7554/eLife.05921.008
The following figure supplements are available for figure 4:
Figure supplement 1. Epithelial Fgfr1 is required for lateral compartment differentiation and HC and SC patterning.
DOI: 10.7554/eLife.05921.009
Figure supplement 2. Generation of an Fgf20Cre knockin mouse line.
DOI: 10.7554/eLife.05921.010

data show that mesenchymal FGFR signaling is a necessary determinant of cochlear length and
sensory progenitor proliferation, but not for cochlear pattern formation or differentiation.
To determine whether the FGF signaling pathway is affected in periotic mesenchyme, whole mount
RNA in situ hybridization was used to localize expression of Etv4 and Etv5, two transcription factors
that are commonly regulated by FGF signaling (Raible and Brand, 2001; Firnberg and Neubüser,
2002; Brent and Tabin, 2004; Mao et al., 2009; Zhang et al., 2009). Compared to double
heterozygous control and Fgf9−/+;Fgf20lacZ/lacZ inner ears, Fgf9−/−;Fgf20lacZ/lacZ inner ears showed
decreased expression of Etv4 and Etv5 in mesenchyme surrounding the cochlear duct
(Figure 6—figure supplement 1A,B). The only known mesenchymal signaling pathway to regulate
sensory progenitor proliferation is a Tbx1/Pou3f4 dependent retinoic acid (RA) signaling cascade
(Braunstein et al., 2008, 2009). However, Tbx1 and Pou3f4 expression, using RNA in situ
hybridization in the embryos lacking Fgf9 and Fgf20 (Fgf9−/−;Fgf20lacZ/lacZ), did not reveal a change
in expression of these transcription factors compared to doble heterozygous control and Fgf9−/+;
Fgf20lacZ/lacZ embryos (Figure 6—figure supplement 1C,D), suggesting that FGF signaling may
function independent of RA signaling.

Mesenchymal FGF signal is sufficient to activate sensory progenitor cells
proliferation
Next we asked whether increased mesenchymal FGFR signaling is sufficient to activate sensory
progenitor proliferation. We ectopically expressed a constitutive FGFR1 tyrosine kinase domain in
mesenchymal cells by combining the Twist2Cre, ROSArtTA, and the doxycycline-responsive TREcaFgfr1-myc alleles (TRE-caFgfr1;ROSArtTA/+::Twist2Cre/+) (Cilvik et al., 2013). Doxycycline was fed to
pregnant female mice beginning at E10.5. Embryos were analyzed at E12.5 for prosensory progenitor
proliferation using pHH3 and Sox2 co-immunostaining (Figure 6A). The proliferation index in control
prosensory cells was 2.4 ± 0.5/10,000 μm2 (Figure 6B). However, embryos in which the caFgfr1-myc
allele was induced in mesenchyme showed a significantly increased (4.1 ± 0.6/10,000 μm2, p < 0.02)
proliferation index (Figure 6B). To test the hypothesis that increased proliferation in sensory
progenitors could lead to an increase in cochlear length, TRE-caFgfr1;ROSArtTA/+::Twist2Cre/+ embryos
were induced from E10.5 to E14.5 and cochleae were analyzed at E18.5 (Figure 6C). Linear densities
of IHCs, OHCs, and SCs in TRE-caFgfr1;ROSArtTA/+::Twist2Cre/+ embryos were comparable (p > 0.4) to
control (Figure 6E,F). However, the cochlear length in TRE-caFgfr1;ROSArtTA/+::Twist2Cre/+ embryos
was significantly (p < 0.001) increased by 14% compared to control (Figure 6D).

Discussion
Sensory progenitor proliferation and differentiation are temporally distinct events in cochlear
development. In mice, sensory progenitors exit from the cell cycle beginning at the apical end of the
cochlea at ∼E12.5 and ending at the base at ∼E14.5. In contrast, differentiation begins in the mid-base
at ∼E14.5 and then extends to the base and apex (Wu and Kelley, 2012). Under physiological
conditions, once progenitors exit the cell cycle, they do not reenter the cell cycle throughout the life of
the organism. Previous studies suggested that during development both epithelial and mesenchymal
signals are required to regulate cochlear progenitor proliferation and differentiation (Montcouquiol
and Kelley, 2003; Doetzlhofer et al., 2004). However, the mechanisms that control cochlear sensory
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Figure 5. Mesenchymal Fgfr1 and Fgfr2 regulate the length of the cochlear duct and sensory progenitor
proliferation. (A, B) Phalloidin (A) and p75 immunostaining (B) of E18.5 whole cochlea showing HCs (phalloidin) and
pillar cells (p75) in the cochlear duct of control, Fgfr1−/f::Twist2Cre/+ (Fgfr1−/f;Fgfr2+/f::Twist2Cre/+), Fgfr2−/f::Twist2Cre/+
Figure 5. continued on next page
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Figure 5. Continued
(Fgfr1+/f;Fgfr2−/f::Twist2Cre/+), and Fgfr1−/f;Fgfr2−/f::Twist2Cre/+ embryos. (C) Phalloidin (green) staining showing normal
HC patterning in the cochlear sensory epithelium. (D) Sox2 immunostaining of E14.5 whole cochlea to identify
progenitor domains (arrows). (E) Sox2 and pHH3 co-immunostaining of E12.5 cochlea sections. (F, G) Measurement
of HC number (F) and length of cochleae (G) of E18.5 control, Fgfr1−/f::Twist2Cre/+ (Fgfr1−/f;Fgfr2+/f::Twist2Cre/+),
Fgfr2−/f::Twist2Cre/+ (Fgfr1+/f;Fgfr2−/f::Twist2Cre/+), and Fgfr1−/f;Fgfr2−/f::Twist2Cre/+ embryos. (H) Measurement of
Sox2+ sensory progenitor (green) proliferation (red, pHH3) in E12.5 embryo sections. All samples were compared with
controls. *p < 0.001. Sample numbers (n) are indicated in data bars. See also Figure 5—figure supplement 1.
DOI: 10.7554/eLife.05921.011
The following figure supplement is available for figure 5:
Figure supplement 1. Twist2Cre targeting of periotic mesenchyme.
DOI: 10.7554/eLife.05921.012

progenitor proliferation are not known. In this study, we found that epithelial FGF9 and FGF20
signaling to mesenchymal FGFR1 and FGFR2 is required for normal levels of cochlear sensory
progenitor proliferation and that inactivation of either the ligands or the mesenchymal receptors
results in a shortened cochlea. We also demonstrated that activation of mesenchymal FGFR signaling
is sufficient to increase sensory progenitor proliferation and extend cochlear length.
Fgf9 is expressed in non-sensory epithelia of the cochlea and loss of Fgf9 results in defects in
periotic mesenchymal cell proliferation, causing a hypoplastic otic capsule (Pirvola et al., 2004).
Based on known expression patterns in mesenchyme, Fgfr1 and Fgfr2 were considered the most likely
targets of FGF9 signaling (Pirvola et al., 2004). The critical time window for FGF9 signaling was
determined to occur before E14.5. By contrast, Fgf20 is expressed in the sensory epithelium and loss
of Fgf20 results in failure of the lateral compartment of the organ of Corti to fully differentiate (Huh
et al., 2012). Based on expression patterns and phenotypic similarities with epithelial Fgfr1
conditional gene inactivation, FGFR1 was identified as the epithelial target receptor (Pirvola et al.,
2002; Huh et al., 2012).
The effects of epithelial FGFR1 signaling on the length of the cochlear duct exhibit variability
among studies. Ono et al. (2014) report a 40–50% decrease in cochlear length in Fgfr1f/f::
Six1enh21Cre, and Fgfr1f/f::Emx2Cre conditional knockout mice, by contrast, Fgf20lacZ/lacZ, Fgf9−/+;
Fgf20lacZ/lacZ, and Fgfr1−/f::Foxg1Cre/+ mice that we studied (Huh et al., 2012, and this study) showed
only a 10–25% decrease in cochlear length. It is clear that in both studies defects in epithelial
differentiation is likely to result in some decrease in cochlear length. It is also possible that differences
in genetic background could contribute to differences in these two studies.
FGF9 and FGF20 are members of the same FGF subfamily and share similar biochemical properties
(Zhang et al., 2006; Ornitz and Itoh, 2015). Redundancy between these FGFs has also been
demonstrated in kidney development, where both ligands are required for nephron progenitor
maintenance (Barak et al., 2012). Interestingly, in both cases, the expression patterns of these two
FGFs do not overlap, but nevertheless they appear to signal to a common target tissue, periotic
mesenchyme in the developing inner ear and CAP mesenchyme in the developing kidney. For the
evolution of the kidney and inner ear, it is possible that additive expression of these FGFs from distinct
sources was required to take advantage of their unique receptor specificities or unique interactions
with the extracellular matrix.
Tbx1 is a transcription factor that is expressed in both sensory epithelium and mesenchyme (Vitelli
et al., 2003; Raft et al., 2004). Deletion of Tbx1 in mesenchymal cells resulted in defects in cochlear
epithelial proliferation indicating a non-cell autonomous requirement for Tbx1 for cochlear epithelial
development (Xu et al., 2007). In addition, the Pou domain containing transcription factor, Pou3f4,
also known as Brn4, is expressed in mesenchymal cells in the developing inner ear (Phippard et al.,
1999). Deletion of Pou3f4 resulted in reduction of cochlear length and defects in derivatives of the
otic mesenchyme including the spiral limbus, scala tympani, and strial fibrocytes (Phippard et al.,
1999). Furthermore, decreasing gene dosages of Tbx1 and Pou3f4 resulted in a significant decrease
in sensory epithelial proliferation and cochlear length indicating that Tbx1 and Pou3f4 genetically
interact. The RA catabolizing genes Cyp26a1 and Cyp26c1, both targets of Tbx1 and Pou3f4, were
decreased in these mice, suggesting that increased RA signaling could directly or indirectly suppress
sensory progenitor proliferation (Braunstein et al., 2008, 2009). Analysis of Fgf9 and Fgf20 double
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Figure 6. Ectopic activation of FGFR signaling in mesenchyme increases sensory progenitor proliferation and
cochlear length. (A) Sox2 (green) and pHH3 (red) co-immunostaining of E12.5 control and TRE-caFgfr1;ROSArtTA/+::
Twist2Cre/+ embryo sections. (B) Measurement of Sox2+ sensory progenitor proliferation at E12.5. (C) Phalloidin
(green) and p75 immunostaining (red) showing the patterning of HCs and pillar cells in the cochlear duct of control
and TRE-caFgfr1;ROSArtTA/+::Twist2Cre/+ embryos. Measurement of the length of the cochleae (D), HC number (E),
and SC number (F) of E18.5 control and TRE-caFgfr1;ROSArtTA/+::Twist2Cre/+ embryos. (G) Schematic diagram
indicating the requirement for epithelial FGF9/20 signaling to mesenchymal FGFR1/2 to induce sensory progenitor
proliferation. *p < 0.01 in B and *p < 0.001 in D. Sample numbers (n) are indicated in data bars. See also
Figure 6—figure supplement 1.
DOI: 10.7554/eLife.05921.013
The following figure supplement is available for figure 6:
Figure supplement 1. Fgf9 and Fgf20 regulate the expression of Etv4 and Etv5, but not Pou3f4 or Tbx1.
DOI: 10.7554/eLife.05921.014
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mutant mice showed no change in the expression of Tbx1 and Pou3f4 in mesenchyme surrounding the
otic vesicle, suggesting that mesenchymal FGF signaling does not directly affect transcription factors
that regulate RA signaling (Figure 6—figure supplement 1C,D). On the other hand, Etv4 and Etv5
function as downstream targets of FGF signaling in other systems including the limb (Mao et al.,
2009; Zhang et al., 2009), and Etv4 and Etv5 expression were decreased in Fgf9/Fgf20 mutant ears.
Future studies will be needed to determine whether FGF signaling including ETV4 and ETV5 regulates
RA signaling downstream of Tbx1/Pou3f4 or act in parallel to the Tbx1/Pou3f4/RA signaling pathway
to regulate sensory progenitor proliferation. Whether the cellular target of RA signaling is in the
periotic mesenchyme or the sensory progenitor epithelium also remains to be determined. It is also
possible that the number of nearby mesenchymal cells may influence sensory progenitor proliferation.
However, considering that loss of Fgf9 resulted in decreased mesenchymal cell proliferation (Pirvola
et al., 2004) but did not affect HC formation or cochlear length (Figure 2), alternative mechanisms
may need to be considered.
The reactivation of developmental signaling pathways may be important for regeneration. Recent
publications showed that inhibition of Notch signaling could induce transdifferentiation of SCs to HCs
in a damaged cochlea (Korrapati et al., 2013; Mizutari et al., 2013). In addition, Wnt/β-catenin
signaling can induce SC proliferation in neonatal mice (Chai et al., 2012; Shi et al., 2012). One
intermediate goal of regenerative biology for the inner ear would be to generate large numbers of
sensory progenitor cells that could be differentiated into functional HCs and SCs and then be
reintroduced into the damaged inner ear. The studies presented here suggest that in efforts to grow
inner ear sensory progenitor cells in vitro, that FGF-induced mesenchyme may be necessary.
The identification of mesenchymal factors that are regulated by FGF or RA could also be used to
support the growth of sensory progenitor cells.

Materials and methods
Generation of Fgf20Cre mutant mice
This study was carried out in strict accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the
Washington University Division of Comparative Medicine Animal Studies Committee (Protocol
Number 20130201). All efforts were made to minimize animal suffering.
Fgf20Cre knock-in mice were generated using a similar method to that reported previously (Huh et al.,
2012). Briefly, exon1 of Fgf20 was replaced with a Cre-EGFP–FRT-neomycin-FRT cassette to generate
Fgf20Cre(neo)/+ mice. The neomycin gene was eliminated by mating with CAG-FLPe (Kanki et al., 2006)
mice to generate Fgf20Cre/+ mice. Genotyping was performed using PCR1: CTGCATTC GCCTCGCCA
CCCTTGCTACACT; PCR2: GGATCTGCAGGTGGAAGCCGGTGCGGCAGT; PCR3: TTCAGGGT
CAGCTTGCCGTAGGTGGCATCG primers, which amplify wild type (335 bp) and mutant (241 bp)
PCR fragments. Mice were maintained on a 129X1/SvJ;C57BL/6J mixed background.

Generation of Fgf9lacZ mutant mice
Fgf9lacZ mice were derived from International Knockout Mouse Consortium targeted ES cells (project
number 24486) (Skarnes et al., 2011). Chimeric mice derived from injected blastocysts were bred to
Sox2Cre mice (Hayashi et al., 2003) to remove the nbactP-neo selection cassette and the second exon
of the Fgf9 gene. Genotyping was performed using Wt1: GAAGTCGTGCGTGAGGTGCTCCAGG
TCGG; Wt2: CCGCGAATGCTGACCAGGCCCACTGCTAT primers for wild type (172 bp) and mut1:
GTT GCA GTGCACGGCAGATACACTTGCTGA; mut2: GCCACTGGTGTGGGCCATAATTCAATTCGC
primers for mutant (389 bp) PCR fragments. Mice were maintained on a 129X1/SvJ;C57BL/6J mixed
background.

Other mouse lines
Fgfr1f/f, Fgfr2f/f, Twist2(Dermo1)Cre/+, Foxg1Cre/+, R26R, ROSAmTmG/+, TRE-caFgfr1-myc, ROSArtTA/+,
Fgf20lacZ/+, and Fgf9−/+ mice lines were reported previously (Soriano, 1999; Hébert and McConnell,
2000; Colvin et al., 2001; Pirvola et al., 2002; Šošić et al., 2003; Yu et al., 2003; Belteki et al.,
2005; Muzumdar et al., 2007; Huh et al., 2012; Cilvik et al., 2013). Fgfr1−/+ and Fgfr2−/+ mice were
generated by crossing Fgfr1f/f and Fgfr2f/f to Sox2Cre/+ mice, respectively.
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βGal staining
Embryos were fixed overnight in Mirsky’s Fixative (National Diagnostics, Atlanta, GA), washed three
times in PBT (PBS, 0.1% Tween-20) and incubated in βGal staining solution (2 mM MgCl2, 35 mM
potassium ferrocyanide, 35 mM potassium ferricyanide, 1 mg/mg X-Gal in PBT) at 37˚C until color
reaction was apparent. Samples were washed in PBS, fixed in 10% formalin and imaged under
a dissecting microscope.

Histology
For frozen sections, embryos were fixed with 4% paraformaldehyde overnight and washed with PBS.
Samples were soaked in 30% sucrose and embedded in OCT compound (Tissue-Tek, Torrance, CA).
Samples were sectioned (12 μm) and stored at −80˚C for immunohistochemistry.

Quantification of HC and SC numbers
Either phalloidin or Prox1 immunostaining were used to identify HCs and SCs, respectively. To
measure the density of HCs and SCs, at least 300 μm regions of the base (10%), middle (40%), and
apex (70%) of the cochleae were counted and normalized to 100 μm along the length of the cochlear
duct. Inner and OHCs were identified by location and morphology of phalloidin staining. Cell counting
was performed using Image J software.

Proliferation and cell death analyses
To analyze progenitor proliferation and cell death, frozen sections were prepared from the entire
ventral inner ear of E11.5 or E12.5 embryos. Alternate sections were subjected to staining for pHH3
and Sox2 (for proliferation) or activated-Caspase 3 and Sox2 (for cell death, data not shown). For EdU
labeling, pregnant females were injected with 50 μg/g (body weight) of EdU according to the
manufacture’s recommendation. Embryos were collected 2 hr after EdU injection. EdU was detected
with the Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen, Carlsbad, CA) according to
manufacture’s instructions. The total area of Sox+ cells was measured using Image J software and
pHH3+ or activated-Caspase 3+ cells within the Sox2+ domain were counted. Counting was normalized
to 10,000 μm2 of Sox2+ prosensory epithelium.

Immunohistochemistry
For whole mount immunofluorescence, cochleae were isolated and fixed in 4% PFA overnight at 4˚C.
Samples were washed with PBS and blocked with PBS containing 0.1% triton X-100 and 0.5% donkey
serum. Primary antibody was incubated overnight at 4˚C. Samples were washed with PBS and
incubated with a secondary antibody for 1 hr at room temperature. Samples were washed, placed on
a glass microscope slide, coverslipped, and photographed using a Zeiss LSM 700 confocal
microscope. For immunofluorescence on histological sections, frozen sections (12 μm) were washed
with PBS, blocked with 0.1% triton X-100 and 0.5% donkey serum, and incubated with primary
antibodies in a humidified chamber overnight at 4˚C. Sections were then washed and incubated with
secondary antibody for 1 hr at room temperature. Samples were washed, coverslipped with
Vectashield Mounting Media (Vector Labs, Burlingame, CA), and photographed using a Zeiss LSM 700
confocal microscope. Primary antibodies used: Phallodin (R&D Systems, Minneapolis, MN, 1:40),
Prox1 (Covance, Princeton, NJ, 1:250), p27 (Neomarkers, Fremont, CA, 1:100), p75 (Chemicon,
Billerica, MA, 1:500), β-galactosidase (Abcam, United Kingdom, 1:500), Sox2 (Millipore, Billerica, MA,
1:250, Santa Cruz, Dallas, TX, 1:250), Jag1 (Santa Cruz, Dallas, TX, 1:200), phospho-histone 3
(Sigma–Aldrich, St. Louis, MO, 1:500), and activated Caspase 3 (BD Sciences, San Jose, CA, 1:200).

Statistics
Numbers of samples are indicated for each experiment. All data are presented as mean ± standard
deviation (sd). The p value for difference between two samples was calculated using a two-tailed
Student’s t-test or one-way ANOVA where appropriate. p < 0.05 was considered as significant.
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